Louise Modis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Protein Degradation in Focus Symposium

PRESS RELEASE Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Protein Degradation in Focus Symposium First presentation of a novel mechanism of

United kingdomAmber fennellAndrea testaLouise modisNamrata taakAmphista therapeuticsScientific coFocus symposiumScientific co founderSenior directorDiscovery chemistryChief scientific officerIhr portfolio

Amphista Therapeutics announces new data demonstrating in vivo efficacy and CNS activity of its mechanistically differentiated targeted protein degraders

Amphista Therapeutics announces new data demonstrating in vivo efficacy and CNS activity of its mechanistically differentiated targeted protein degraders
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomStefan klotterBeverley carrNamrata taakAmber fennellLouise modisAmphista therapeutics the company orAmphista therapeuticsChief scientific officerInterim chief executive officerDie performance strategieAssets sie

Amphista Therapeutics Achieves First Milestone in Second Discovery Programme with Bristol Myers Squibb

Amphista Therapeutics Achieves First Milestone in Second Discovery Programme with Bristol Myers Squibb
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomAlessio ciulliConsiliumamber fennellBristol myers squibbNamrata taakLouise modisDementia discovery fundUniversity of dundeeEli lilly companyAdvent life sciencesNovartis venture fundAmphista therapeutics the company orTherapeutics achieves first milestoneSecond discovery programmeBristol myersAmphista therapeutics

Amphista Therapeutics Expands Senior Team and Announces Appointment of Louise Modis as Chief Scientific Officer and Ian Churcher as Chief Technology Officer

/PRNewswire/ Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD), today announced that Louise Modis, PhD, has joined the.

Baden wübergUnited kingdomNicola thompsonAlessio ciulliLouise modisLynn granitoIan churcherDementia discovery fundMillennium pharmaceuticalsAmphista therapeuticsUniversity of dundeeNovartis venture fundImmunology network at glaxosmithklineEli lilly companyBoehringer ingelheimBerry company public relations

Mogrify and Astellas announce collaboration to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing loss

/PRNewswire/ Mogrify Limited (CEO: Darrin M. Disley, Ph.D., "Mogrify®"), a biopharmaceutical company transforming the lives of patients through a novel.

City ofUnited kingdomUnited statesNorth carolinaSouth san franciscoSan franciscoJonathan milnerMathew pletcherLinkedin mogrifyLouise modisDarrinm disleyJ public healthTrend investment groupAstellas pharma incUniversity of bristol enterprise fundZyme communications